86 related articles for article (PubMed ID: 16762882)
1. [Expression of TGFbeta1 and its type I receptors ALK1 and ALK5 mRNA in brain arteriovenous malformation].
Chen GZ; Li TL; Quan W; Huang T; Zhao QP; Wang JQ; Duan CZ; Wang QJ; Jiang XD
Nan Fang Yi Ke Da Xue Xue Bao; 2006 May; 26(5):675-7. PubMed ID: 16762882
[TBL] [Abstract][Full Text] [Related]
2. Activin Receptor-Like Kinase Receptors ALK5 and ALK1 Are Both Required for TGFβ-Induced Chondrogenic Differentiation of Human Bone Marrow-Derived Mesenchymal Stem Cells.
de Kroon LM; Narcisi R; Blaney Davidson EN; Cleary MA; van Beuningen HM; Koevoet WJ; van Osch GJ; van der Kraan PM
PLoS One; 2015; 10(12):e0146124. PubMed ID: 26720610
[TBL] [Abstract][Full Text] [Related]
3. Expression of vascular endothelial growth factor is coordinately regulated by the activin-like kinase receptors 1 and 5 in endothelial cells.
Shao ES; Lin L; Yao Y; Boström KI
Blood; 2009 Sep; 114(10):2197-206. PubMed ID: 19506300
[TBL] [Abstract][Full Text] [Related]
4. TGFbeta1 induces vasculogenesis and inhibits angiogenic sprouting in an embryonic stem cell differentiation model: respective contribution of ALK1 and ALK5.
Mallet C; Vittet D; Feige JJ; Bailly S
Stem Cells; 2006 Nov; 24(11):2420-7. PubMed ID: 17071858
[TBL] [Abstract][Full Text] [Related]
5. ALK1 opposes ALK5/Smad3 signaling and expression of extracellular matrix components in human chondrocytes.
Finnson KW; Parker WL; ten Dijke P; Thorikay M; Philip A
J Bone Miner Res; 2008 Jun; 23(6):896-906. PubMed ID: 18333754
[TBL] [Abstract][Full Text] [Related]
6. Increase in ALK1/ALK5 ratio as a cause for elevated MMP-13 expression in osteoarthritis in humans and mice.
Blaney Davidson EN; Remst DF; Vitters EL; van Beuningen HM; Blom AB; Goumans MJ; van den Berg WB; van der Kraan PM
J Immunol; 2009 Jun; 182(12):7937-45. PubMed ID: 19494318
[TBL] [Abstract][Full Text] [Related]
7. Remodeling retinal neovascularization by ALK1 gene transfection in vitro.
Li B; Yin W; Hong X; Shi Y; Wang HS; Lin SF; Tang SB
Invest Ophthalmol Vis Sci; 2008 Oct; 49(10):4553-60. PubMed ID: 18829861
[TBL] [Abstract][Full Text] [Related]
8. Thalidomide Reduces Hemorrhage of Brain Arteriovenous Malformations in a Mouse Model.
Zhu W; Chen W; Zou D; Wang L; Bao C; Zhan L; Saw D; Wang S; Winkler E; Li Z; Zhang M; Shen F; Shaligram S; Lawton M; Su H
Stroke; 2018 May; 49(5):1232-1240. PubMed ID: 29593101
[TBL] [Abstract][Full Text] [Related]
9. ALK5- and TGFBR2-independent role of ALK1 in the pathogenesis of hereditary hemorrhagic telangiectasia type 2.
Park SO; Lee YJ; Seki T; Hong KH; Fliess N; Jiang Z; Park A; Wu X; Kaartinen V; Roman BL; Oh SP
Blood; 2008 Jan; 111(2):633-42. PubMed ID: 17911384
[TBL] [Abstract][Full Text] [Related]
10. Susceptible gene single nucleotide polymorphism and hemorrhage risk in patients with brain arteriovenous malformation.
Jiang N; Li X; Qi T; Guo S; Liang F; Huang Z
J Clin Neurosci; 2011 Sep; 18(9):1279-81. PubMed ID: 21737283
[TBL] [Abstract][Full Text] [Related]
11. Induction of Brain Arteriovenous Malformation Through CRISPR/Cas9-Mediated Somatic Alk1 Gene Mutations in Adult Mice.
Zhu W; Saw D; Weiss M; Sun Z; Wei M; Shaligram S; Wang S; Su H
Transl Stroke Res; 2019 Oct; 10(5):557-565. PubMed ID: 30511203
[TBL] [Abstract][Full Text] [Related]
12. Nonoverlapping expression patterns of ALK1 and ALK5 reveal distinct roles of each receptor in vascular development.
Seki T; Hong KH; Oh SP
Lab Invest; 2006 Feb; 86(2):116-29. PubMed ID: 16344855
[TBL] [Abstract][Full Text] [Related]
13. Tumor-specific expression and alternate splicing of messenger ribonucleic acid encoding activin/transforming growth factor-beta receptors in human pituitary adenomas.
Alexander JM; Bikkal HA; Zervas NT; Laws ER; Klibanski A
J Clin Endocrinol Metab; 1996 Feb; 81(2):783-90. PubMed ID: 8636304
[TBL] [Abstract][Full Text] [Related]
14. TGFβ1-mediated PI3K/Akt and p38 MAP kinase dependent alternative splicing of fibronectin extra domain A in human podocyte culture.
Madne TH; Dockrell MEC
Cell Mol Biol (Noisy-le-grand); 2018 Apr; 64(5):127-135. PubMed ID: 29729706
[TBL] [Abstract][Full Text] [Related]
15. Distinct regulation of gene expression in human endothelial cells by TGF-beta and its receptors.
Wu X; Ma J; Han JD; Wang N; Chen YG
Microvasc Res; 2006 Jan; 71(1):12-9. PubMed ID: 16405919
[TBL] [Abstract][Full Text] [Related]
16. Bone Marrow-Derived Alk1 Mutant Endothelial Cells and Clonally Expanded Somatic Alk1 Mutant Endothelial Cells Contribute to the Development of Brain Arteriovenous Malformations in Mice.
Shaligram SS; Zhang R; Zhu W; Ma L; Luo M; Li Q; Weiss M; Arnold T; Santander N; Liang R; do Prado L; Tang C; Pan F; Oh SP; Pan P; Su H
Transl Stroke Res; 2022 Jun; 13(3):494-504. PubMed ID: 34674144
[TBL] [Abstract][Full Text] [Related]
17. Expression of TGFbeta1 and its signaling components by peripheral lymphocytes in systemic lupus erythematosus.
Kohut E; Hajdu M; Gergely P; Gopcsa L; Kilián K; Pálóczi K; Kopper L; Sebestyén A
Pathol Oncol Res; 2009 Jun; 15(2):251-6. PubMed ID: 19020994
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the prognostic value of TGF-β superfamily type I receptor and TGF-β type II receptor expression in nasopharyngeal carcinoma using high-throughput tissue microarrays.
Zhang W; Zeng Z; Fan S; Wang J; Yang J; Zhou Y; Li X; Huang D; Liang F; Wu M; Tang K; Cao L; Li X; Xiong W; Li G
J Mol Histol; 2012 Jun; 43(3):297-306. PubMed ID: 22391627
[TBL] [Abstract][Full Text] [Related]
19. L- and S-endoglin differentially modulate TGFbeta1 signaling mediated by ALK1 and ALK5 in L6E9 myoblasts.
Velasco S; Alvarez-Muñoz P; Pericacho M; Dijke PT; Bernabéu C; López-Novoa JM; Rodríguez-Barbero A
J Cell Sci; 2008 Mar; 121(Pt 6):913-9. PubMed ID: 18303046
[TBL] [Abstract][Full Text] [Related]
20. Mutational analysis of activin/transforming growth factor-beta type I and type II receptor kinases in human pituitary tumors.
D'Abronzo FH; Swearingen B; Klibanski A; Alexander JM
J Clin Endocrinol Metab; 1999 May; 84(5):1716-21. PubMed ID: 10323406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
